CN110368478A - 一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴 - Google Patents
一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴 Download PDFInfo
- Publication number
- CN110368478A CN110368478A CN201910747862.3A CN201910747862A CN110368478A CN 110368478 A CN110368478 A CN 110368478A CN 201910747862 A CN201910747862 A CN 201910747862A CN 110368478 A CN110368478 A CN 110368478A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- sea salt
- traditional chinese
- salt mud
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 173
- 235000002639 sodium chloride Nutrition 0.000 title claims abstract description 128
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title claims abstract description 95
- 239000011780 sodium chloride Substances 0.000 title claims abstract description 94
- 239000011505 plaster Substances 0.000 title claims abstract description 67
- 230000002269 spontaneous effect Effects 0.000 title claims abstract description 51
- 238000010438 heat treatment Methods 0.000 title claims abstract description 47
- 206010028391 Musculoskeletal Pain Diseases 0.000 title claims abstract description 38
- 208000007613 Shoulder Pain Diseases 0.000 title claims abstract description 38
- 239000004615 ingredient Substances 0.000 claims abstract description 35
- 239000002674 ointment Substances 0.000 claims abstract description 22
- 229940079593 drug Drugs 0.000 claims description 28
- 244000163122 Curcuma domestica Species 0.000 claims description 20
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 20
- 235000003373 curcuma longa Nutrition 0.000 claims description 20
- 235000013976 turmeric Nutrition 0.000 claims description 20
- 235000013399 edible fruits Nutrition 0.000 claims description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 17
- 241000180649 Panax notoginseng Species 0.000 claims description 17
- 239000008187 granular material Substances 0.000 claims description 17
- 244000189799 Asimina triloba Species 0.000 claims description 16
- 235000006264 Asimina triloba Nutrition 0.000 claims description 16
- 235000009467 Carica papaya Nutrition 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 16
- 240000000249 Morus alba Species 0.000 claims description 16
- 235000008708 Morus alba Nutrition 0.000 claims description 16
- 244000046146 Pueraria lobata Species 0.000 claims description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 16
- 244000089698 Zanthoxylum simulans Species 0.000 claims description 16
- 241000270273 Ptyas dhumnades Species 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 235000019082 Osmanthus Nutrition 0.000 claims description 4
- 241000333181 Osmanthus Species 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 4
- 235000013372 meat Nutrition 0.000 claims description 4
- 238000012797 qualification Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000010257 thawing Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229920006280 packaging film Polymers 0.000 claims description 3
- 239000012785 packaging film Substances 0.000 claims description 3
- 239000005439 thermosphere Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 53
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 230000017531 blood circulation Effects 0.000 abstract description 16
- 230000000202 analgesic effect Effects 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 11
- 230000001225 therapeutic effect Effects 0.000 abstract description 11
- 230000000857 drug effect Effects 0.000 abstract description 5
- 208000007101 Muscle Cramp Diseases 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 63
- 208000002193 Pain Diseases 0.000 description 45
- 230000036407 pain Effects 0.000 description 44
- 150000003839 salts Chemical class 0.000 description 34
- 239000002002 slurry Substances 0.000 description 32
- 210000004369 blood Anatomy 0.000 description 29
- 239000008280 blood Substances 0.000 description 28
- 230000006870 function Effects 0.000 description 28
- 201000010099 disease Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 22
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 210000003141 lower extremity Anatomy 0.000 description 18
- 210000001624 hip Anatomy 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 17
- 230000010415 tropism Effects 0.000 description 14
- 230000005856 abnormality Effects 0.000 description 13
- 230000002146 bilateral effect Effects 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 12
- 208000008035 Back Pain Diseases 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 206010016256 fatigue Diseases 0.000 description 8
- 230000003387 muscular Effects 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 208000008930 Low Back Pain Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 210000001364 upper extremity Anatomy 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000037336 dry skin Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010034464 Periarthritis Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 210000000323 shoulder joint Anatomy 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000717739 Boswellia sacra Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 240000004307 Citrus medica Species 0.000 description 2
- 240000007311 Commiphora myrrha Species 0.000 description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- 206010016228 Fasciitis Diseases 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000195947 Lycopodium Species 0.000 description 2
- 241000489861 Maximus Species 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- 208000001294 Nociceptive Pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 208000036319 cervical spondylosis Diseases 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 208000005801 spondylosis Diseases 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 208000004760 Tenosynovitis Diseases 0.000 description 1
- 241001078983 Tetradium ruticarpum Species 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FSHXODRICVTBJO-UHFFFAOYSA-N benzene-1,2-diol;benzene-1,4-diol Chemical compound OC1=CC=C(O)C=C1.OC1=CC=CC=C1O FSHXODRICVTBJO-UHFFFAOYSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000000852 deltoid muscle Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000005433 ionosphere Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000001247 metal acetylides Chemical class 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000010831 paired-sample T-test Methods 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000002097 psoas muscle Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 229920006300 shrink film Polymers 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 208000029761 vertebral disease Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- -1 vitamin nucleic acid Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F7/03—Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0261—Compresses or poultices for effecting heating or cooling medicated
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Thermal Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
Abstract
本发明属于药物制剂技术领域,公开了一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴;利用海盐泥与中药方剂结合,用于缓解颈肩腰背疼痛的自发热海盐泥中药贴。本发明提自发热海盐泥中药贴,分为药膏贴与自发热材料上下两层,其中药膏贴中含有海盐泥和中药成分,海盐泥和中药成分的质量比为1:1。本发明的自发热体,可使中药有效成分直接渗入病变部位,充分发挥药效,起到消肿、止痛、活血、通络以及解除肌肉痉挛等作用,达到治疗目的。本发明的自发热海泥药物贴具有缓解颈肩腰背疼痛的功效,可代替传统灸疗的产品,使用简单方便,便于携带,疗效显著,可在家享受海泥灸疗。
Description
技术领域
本发明属于药物制剂技术领域,尤其涉及一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴。
背景技术
目前,最接近的现有技术:传统中医认为人生赖阳气为根本,得其所则人寿、失其所则人夭,故阳病则阴盛、阴盛则为寒,或元气虚陷,脉微欲脱,此时,就要用灸来温补虚脱的阳气。根据中医脏腑经络理论和全息理论,认为通过温灸能调整人体脏腑经络气血,即:调节人体生理机能,提高免疫功能,达到强身健体、防病保健的目的。热灸是针灸学里灸疗的一种,与汤药、针刺并列为中医三大疗法,至今己有数千年的历史,马王堆出土的春秋战国时期帛书《足臂十一脉灸经》《阴阳十一脉灸经》就有关于灸法的记载。历代医家对灸法推崇备至《灵枢·官能》云:“针所不为,灸之所宜”,《扁鹊心书》曰:“保命之法,艾灼第一”,《医学入门》则强调“凡病药之不及,针之不到,必须灸之”。
传统艾灸都是用艾草作发热体,但使用起来不方便,因其燃烧缓慢、效率不高、烟雾较大、刺鼻、熏眼、易于灼伤、操作不便等缺陷。而艾烟中苯酚、邻苯二酚·对苯二酚等成分高浓度时会有一定的毒性。有学者对艾灸诊室进行环境监控,发现艾灸生成物对环境空气产生一定的影响,增加诊室内PM10含量,细颗粒尤其是二次粒子在艾灸诊室PM10中占有相当大的比例,艾灸诊室PM10浓度超过医院候诊室卫生标准(GB9671-1996)。现代生物医学认为艾灸是以红外为主的热辐射刺激,其次才是药物作用,即灸疗的实质是一种温热刺激的结果,通过刺激皮肤感受器,激发和调整神经系统的机能。
目前市场上热灸贴的种类很多,主要是利用其热灸贴的热量以达到散寒止痛的作用,因其治疗作用单一,故未在临床中广泛推广。
古人云:“土者五行之主,坤之体也。水为万化之源,土为万物之母。昔人分别九州水土,以辨人之美恶寿天”。古今中外,常以泥土治病,亦以泥土养颜美容。将海泥结合中药外用领域还未见报道。
综上所述,现有技术存在的问题是:
(1)目前市场上热灸贴利用其热灸贴的热量以达到散寒止痛的作用,治疗作用单一。
(2)将海泥结合中药外用领域还未见报道。
发明内容
针对现有技术存在的问题,本发明提供了一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴。
本发明是这样实现的,一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴为药膏层与自发热层上下两层;药膏贴中含有海盐泥和中药成分;海盐泥和中药成分的质量比为1:1。
进一步,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的中药成分按照重量份数由当归2-6份、杜仲叶2-6份、乌梢蛇2-6份、木瓜1-3份、三七1-3份、葛根3-9份、姜黄2-6份、花椒2-6份、山茱萸1-3份、黄芪2-6份、肉桂1-3份、枸杞子1-3份、干姜1-3份、桑椹2-6份和甘草1-3份组成。
进一步,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴中药成分按照重量份数由当归2份、杜仲叶2份、乌梢蛇2份、木瓜1份、三七1份、葛根3份、姜黄2份、花椒2份、山茱萸1份、黄芪2份、肉桂1份、枸杞子1份、干姜1份、桑椹2份和甘草1份组成。
进一步,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴中药成分按照重量份数由当归4份、杜仲叶4份、乌梢蛇4份、木瓜2份、三七2份、葛根6份、姜黄4份、花椒4份、山茱萸2份、黄芪4份、肉桂2份、枸杞子2份、干姜2份、桑椹4份和甘草2份组成。
进一步,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴中药成分按照重量份数由当归6份、杜仲叶6份、乌梢蛇6份、木瓜3份、三七3份、葛根9份、姜黄6份、花椒6份、山茱萸3份、黄芪6份、肉桂3份、枸杞子3份、干姜3份、桑椹6份和甘草3份组成。
本发明的另一目的在于提供一种所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的制备方法,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的制备方法包括:
步骤一,对原材料去外衣和消毒;
步骤二,分别称取海盐泥及中药饮片颗粒剂,干燥处理,干燥温度控制在35-40℃;
步骤三,分别将海盐泥和中药饮片颗粒剂放入打粉机中打成海盐泥粉及中药颗粒粉剂,样品筛为200目;
步骤四,将医用压敏膏药胶加热到130°融化后先后放入中药粉剂及海盐泥粉剂,制成药膏放入防渗圈中;
步骤五,将步骤四中的药膏贴与自发热包粘贴在一起;
步骤六,将做好的小包装产品打好相应生产日期,套好包装膜进行热收缩;
步骤七,成品放入库房的产品合格区。
综上所述,本发明的优点及积极效果为:本发明提供的是缓解颈肩腰背疼痛的中药配方,根据中医药的配伍原则,将十五味中药进行组方,有效增强各成分的原有药效,使各成分相辅相成,产生良好的协同作用。另外,该中药配方所用的原料均来源于《中国药典》的道地药材,均为国家卫健委最新发布(2018)版药食同源中药,无毒副作用。经过大量临床试验证实,以上方药结合TDP照射,对于软组织疼痛有明显的缓解作用。经过发明者的改良,将以上有效的方剂、海盐泥及自发热体三者结合在一起,既达到治疗疾病的作用,又方便患者的使用,具有潜在的社会效益。
本发明的自发热体,可使中药有效成分直接渗入病变部位,充分发挥药效,起到消肿、止痛、活血、通络以及解除肌肉痉挛等作用,达到治疗目的。
本发明的发明人长期从事于临床工作发现,海盐泥结合中药复方治疗软组织疼痛方面有着较好的临床效果。如果利用热灸贴的热量与海盐泥中药复方结合,不但可以增加疗效,而且便于携带,易于接受。海泥是一种深海中矿物泥,内含多种人体所需生物成份和丰富的矿物质,其特有的孔状结构,具有超凡的吸附能力。海盐泥中的矿物质,可以络合在有机物下形成更具有生物原性的络合物,更容易被肌肤吸收和利用,其矿物活性成分对各种皮肤病有理疗作用;通过渗透离子促进血液循环,增进新陈代谢,排除皮肤杂质,恢复皮肤弹性。海盐泥还能释放大量的远红外线,内含的矿物质、藻元素以及化妆品成分中的膨润土成分,有益于皮肤美容,防止皮肤老化,收缩皮肤毛孔。可以说,海盐泥是天然美容护肤中的极品。
附图说明
图1是本发明实施例提供的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的制备方法流程图。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
针对目前市场上热灸贴利用其热灸贴的热量以达到散寒止痛的作用,治疗作用单一;将海泥结合中药外用领域还未见报道的问题。本发明提供一种海盐泥与中药相结合制作成热灸贴,具有缓解颈肩腰背疼痛的功效,可代替传统灸疗的产品,使用简单方便,便于携带,疗效显著,即可在家享受海盐泥中药灸疗。
下面结合附图对本发明的应用原理作详细的描述。
本发明实施例提供的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴分为药膏层与自发热层上下两层;其中药膏贴中含有海盐泥和中药成分。
海盐泥和中药成分的质量比为1:1,本发明所采用的海盐泥均来自于营口渤海海域盐场的晒盐池下海盐泥。
中药成分由如下重量份数的中药饮片颗粒剂原料由当归2-6份、杜仲叶2-6份、乌梢蛇2-6份、木瓜1-3份、三七1-3份、葛根3-9份、姜黄2-6份、花椒2-6份、山茱萸1-3份、黄芪2-6份、肉桂1-3份、枸杞子1-3份、干姜1-3份、桑椹2-6份和甘草1-3份组成。
中药成分的药理作用如下:
当归:性味:甘、辛,温。归经:归肝、心、脾经。功能主治:当归味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,为血中之要药。因而,它既能补血,又能活血,既可通经,又能活络。
杜仲叶:性味:微辛,温。归经:归肝、肾经。功能主治:功能补肝肾,强筋骨。适用于肝肾不足,头晕目眩,腰膝酸痛,筋骨痿软。
乌梢蛇:性味:甘,平。归经:归肝经。功能主治:功能祛风、通络、止痉。本品性走窜,能搜风邪,利关节,常用于风湿痹症。
木瓜:性味:酸,温。归经:归肝、脾经。功能主治:舒筋活络,和胃化湿。本品味酸入肝,善于舒筋活络,且能祛湿除痹,尤为湿痹筋脉拘挛之要药,亦常用于腰膝关节酸肿。
三七:性味:甘、微苦,温。归经:归肝、胃经。功能主治:化瘀止血,活血定痛。本品味甘微苦性温,入肝经血分,功善止血,又能化瘀生新,有止血不留瘀,化瘀不伤正的特点。对人体内外各种出血无论有无瘀滞,均可应用,尤以有瘀滞者为宜,为治瘀血诸症之佳品,为伤科之要药。
葛根:性味:甘、辛,凉。归经:归脾、胃、肺经。功能主治:解肌退热,生津止渴,透疹,升阳止泻,通经活络,解酒毒。本品甘辛性凉,轻扬升散,具有发汗解表,解肌退热之功。
姜黄:性味:辛、苦,温。归经:归肝、脾经。功能主治:活血行气,通经止痛。姜黄辛行苦泄,温散通滞,既入血分,又入气分,长于止痛,善治气滞血瘀诸痛症。姜黄辛散苦燥,温通经脉,能祛除关节经络之风寒湿邪,通行气血而通络止痛。
花椒:性味:辛,温。归经:归脾、胃、肾经。功能主治:温中止痛,杀虫止痒。本品辛散温燥,入脾胃经,长于温中燥湿、散寒止痛、止呕止
山茱萸:性味:酸、涩,微温。归经:归肝、肾经。功能主治:补益肝肾,收敛固涩。本品酸涩微温质润,其性温而不燥,补而不峻,功善补益肝肾,既能益精,又可助阳,为平补阴阳之要药。
黄芪:性味:甘,微温。归经:归脾、肺经。功能主治:补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。本品能补气以行血,补气以通痹。
肉桂:性味:辛、甘,大热。归经:归肾、脾、心、肝经。功能主治:补火助阳,散寒止痛,温通经脉,引火归元。本品辛甘大热,益阳消阴,为治命门火衰之要药。本品辛散温通,能行气血,通经脉,散寒止痛。
枸杞子:性味:甘、酸,寒。归经:归肾、肝经。功能主治:滋补肝肾,益气明目。本品甘平,入肝肾经,长于滋肾精,补肝血,为平补肾精肝血之品。主治肝肾阴虚,精血不足所致的腰膝酸痛,眩晕耳鸣等症。
干姜:性味:辛,热。归经:归脾、胃、肾、心、肺经。功能主治:温中散寒,回阳通脉,温肺化饮。本品辛热燥烈,主入脾胃而长于温中散寒,健运脾阳,为温暖中焦之主药。
桑椹:性味:甘、酸,寒。归经:归心、肝、肾经。功能主治:滋阴补血,生津润燥。本品甘酸,滋补阴血,《滇南本草》言其“益肾脏而固精,久服黑发明目”,故常用于肝肾不足,阴血亏虚之腰膝酸软,眩晕耳鸣等症。
甘草:性平,味甘。归心经、胃经、脾经、肺经。功效与作用:补脾益气、止咳祛痰、缓急定痛、调和药性。
本发明由当归4份、杜仲叶4份、乌梢蛇4份、木瓜2份、三七2份、葛根6份、姜黄4份、花椒4份、山茱萸2份、黄芪4份、肉桂2份、枸杞子2份、干姜2份、桑椹4份、甘草2份。方中君药:当归补血活血通经,且能改善微循环,加快血液流速;臣药:杜仲叶、花椒,干姜,肉桂祛风散寒,强筋止痛;黄芪、葛根、姜黄,,三七补气解肌,活血化瘀止痛;木瓜、乌梢蛇祛风除湿通络止痛;佐以吴茱萸,枸杞子,桑椹以加强补肝益肾、强腰健骨之功效;甘草调和诸药,诸药合用共奏活血祛瘀、散寒祛风,除湿通络、补肝益肾、舒筋止痛之功效。再加上自发热体,可使药物有效成分直接渗入病变部位,充分发挥药效,起到消肿、止痛、活血、通络以及解除肌肉痉挛等作用,从而达到治疗目的。
本发明实施例的中药成分由如下重量份数的中药饮片颗粒剂原料由当归4份、杜仲叶4份、乌梢蛇4份、木瓜2份、三七2份、葛根6份、姜黄4份、花椒4份、山茱萸2份、黄芪4份、肉桂2份、枸杞子2份、干姜2份、桑椹4份和甘草2份组成。
本发明实施例的中药成分由如下重量份数的中药饮片颗粒剂原料由当归6份、杜仲叶6份、乌梢蛇6份、木瓜3份、三七3份、葛根9份、姜黄6份、花椒6份、山茱萸3份、黄芪6份、肉桂3份、枸杞子3份、干姜3份、桑椹6份和甘草3份组成。
如图1所示,本发明实施例提供的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的制备方法包括以下步骤:
S101:预处理:凭生产指令领取物料并核对物料代号、品名、规格、编号和重量等,并进行去外衣和消毒;
S102:干燥:分别称取海盐泥及中药饮片颗粒剂,进行干燥处理,干燥温度控制在35-40℃;
S103:成粉:分别将海盐泥和中药饮片颗粒剂放入打粉机中打成海盐泥粉及中药颗粒粉剂,样品筛为200目;
S104:成膏:将医用压敏膏药胶加热到130°融化后先后放入中药粉剂及海盐泥粉剂,制成药膏放入防渗圈中;
S105:混合填充:将步骤S104中的药膏贴与自发热包粘贴在一起;
S106:热收缩:将做好的小包装产品打好相应生产日期,套好包装膜进行热收缩;
S107:入库:成品放入库房的产品合格区。
下面结合具体实施例对本发明的应用原理作进一步的描述。
实施例1
本发明实施例的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,海盐泥中药贴分为药膏贴与自发热材料上下两层,药膏贴中含有海盐泥和中药成分,海盐泥和中药成分的质量比为1:1。中药成分由如下重量份数的中药饮片颗粒剂原料组成的:当归2份、杜仲叶2份、乌梢蛇2份、木瓜1份、三七1份、葛根3份、姜黄2份、花椒2份、山茱萸1份、黄芪2份、肉桂1份、枸杞子1份、干姜1份、桑椹2份、甘草1份。
本发明实施例提供的中药配方的制备方法,包括以下步骤。
步骤一、预处理:凭生产指令领取物料并核对物料代号、品名、规格、编号和重量等;
步骤二、干燥:分别按比例称取海盐泥及中药饮片颗粒剂,进行干燥处理,干燥温度控制在35-40℃;
步骤三、成粉:分别将海盐泥及中药饮片颗粒剂放入打粉机(永历YF10-1)中打成海盐泥粉及中药粉剂,样品筛为200目;
步骤四、成膏:将医用压敏膏药胶加热至130°融化后,先后放入中药粉剂及海泥粉剂,制成药膏放入6×9cm防渗圈中;
步骤五、混合填充:将步骤四中的药膏贴与自发热包(铁粉(Fe)、活性碳(C)、无机盐(NaCl)、水(H2O)、氧气(O2)、蛭石(Mg0.5(H2O)4Mg3[AlSi3O10](OH)2)、吸水性树脂混合)(河北厚德汉方医疗器械股份有限公司所提供)粘贴在一起;
步骤六、热收缩:将做好的小包装产品打好相应生产日期,套好热收缩膜进行热收缩(得力14885);
步骤七、入库:成品放入库房的产品合格区。
实施例2
本发明实施例的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,海盐泥中药贴分为药膏贴与自发热材料上下两层,药膏贴中含有海盐泥和中药成分,海盐泥和中药成分的质量比为1:1。中药成分由如下重量份数的中药饮片颗粒剂原料组成的:当归4份、杜仲叶4份、乌梢蛇4份、木瓜2份、三七2份、葛根6份、姜黄4份、花椒4份、山茱萸2份、黄芪4份、肉桂2份、枸杞子2份、干姜2份、桑椹4份、甘草2份。制备方法同实施例1。
实施例3
本发明实施例的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,海盐泥中药贴分为药膏贴与自发热材料上下两层,药膏贴中含有海盐泥和中药成分,海盐泥和中药成分的质量比为1:1。中药成分由如下重量份数的中药饮片颗粒剂原料组成的:姜黄6份、白芷6份、防风6份、没药6份、大黄6份、秦艽4份、延胡索6份、三七6份、桃仁10份、红花6份、乳香6份、莪术4份、细辛2份、冰片3份、当归6份、伸筋草9份。制备方法同实施例1。
下面结合实验对本发明的应用效果作详细的描述。
1、临床对照实验
将实施例1的中药方剂打成粉末后将75%酒精融合,再结合TDP照射使其发挥活血化瘀、散寒止痛的作用,可获得良好的疗效,但是使用不方便。为了解决上述技术问题,申请人将中药方剂与海盐泥和自发材料相结合,使用起来简单方便,效果显著,轻轻松松即可在家享受海泥灸疗。
1.1本发明收集40例颈肩腰背痛病例,均为门诊就诊患者,治疗组患者年龄22-57岁,平均(39.90±9.65)岁,病程2-33个月,平均(11.00±7,78)个月,治疗组采用的是实施例1制得的海盐泥中药贴。
对照组患者年龄20-52岁,平均(38.35±8.75)岁,病程2-36个月,平均(11.60±8.72)个月,对照组采用的是海盐泥加行气活血类中药组成的灸贴,其组成:姜黄4份、红花4份、延胡索4份、乳香2份、没药2份、伸筋草6份、郁金4份、青皮4份、枳实2份、木香4份、香附2份、川芎2份、橘皮2份、香橼4份、甘草2份。制作方法同治疗组。
所有患者经医学伦理委员会批准通过,患者签署知情同意书。按完全随机数字表法分为治疗组(20例)、对照组(20例)。二组患者性别、年龄、病程比较差异无统计学意义(均P>0.05),具有可比性。见表1.。
表1一般资料
组别 | 例数 | 年龄 | VAS评分 | 病程 |
治疗组 | 20 | 39.90±9.65 | 4.95±1.23 | 11.00±7.78 |
对照组 | 20 | 38.35±8.75 | 4.85±1.22 | 11.60±8.72 |
1.2病例入选标准
1.2.1诊断标准
参照《中医病证诊断疗效标准》:(1)可有外伤后治疗不当、劳损或外感风寒等病史;(2)背部酸痛,肌肉僵硬发板,有沉重感,疼痛常与天气变化有关,阴雨天及劳累后可使症状加重;(3)背部有固定压痛点或压痛较为广泛;(4)背部肌肉僵梗,沿骶棘肌行走方向常可触到条索状的改变,颈肩腰背功能活动大多正常(5)X线摄片检查无阳性征;(6)晨起背部板硬刺痛,活动后减轻。舌质暗紫,或有瘀斑,脉弦紧或涩。。
1.2.2纳入标准
(1)符合上述诊断标准;(2)年龄18-80岁;(3)自愿参与研究且签署知情同意书者。
1.2.3排除标准
(1)不符合诊断标准;(2)年龄在18岁以下或80岁以上;(3)伴有严重心血管、肝、肾及造血系统疾病的患者;(4)患骨折、脊柱滑脱、肿瘤等疾病患者;(5)妊娠患者;(6)皮肤过敏史者。
1.2.4剔除标准
已纳入研究患者,符合以下一项,应剔除:(1)误诊;(2)采取禁用疗法不能客观地评价疗效者;(3)未按时接受治疗者。
1.2.5盲法设计及实施
本发明采用患者盲,即患者不知道采用何种治疗方法。由第三方进行疗效评价及统计学处理。
2治疗方案
2.1治疗组:采用本发明的海盐泥中药贴,具体方法如下:
取点:取患者压痛点。
操作方法:患者俯卧位,消毒,患者局部皮肤无红肿热痛,将海盐泥中药贴外敷于局部。1天治疗1次,共治疗14次。
2.2对照组:治疗方法同治疗组。
3疗效观察
3.1观察指标
记录治疗前、治疗后1周、1个月、3个月、6个月的视觉模拟量评分(visualanalogue scale,VAS);治疗后3个月、6个月的疗效评定;观察不良反应发生情况(皮肤过敏、皮损、感染等)。
3.2疗效评定标准
参照《中医病证诊断疗效标准》,治愈:颈肩腰痛症状消失,颈肩腰部活动自如。好转:颈肩腰痛减轻,颈肩腰部活动功能基本恢复。未愈:症状未改善。
在治疗结束后进行疗效评价并记录。
4统计学处理
应用SPSS20.0统计软件处理相关数据,计量资料均数±标准差(x±s)表示,如数据符合正态分布,采用独立样本t检验进行组间对比,采用配对样本t检验进行组内对比,以P<0.05为差异有统计学意义;如数据不符合正态分布,采用Mann-whitney U检验进行组间对比,Wilcoxon检验进行组内对比,以P<0.05为差异有统计学意义。
5治疗结果
两组患者治疗前VAS评分及ODI值比较,差异无统计学意义(P>0.05);与治疗前比较,两组患者治疗后各个时点VAS评分和ODI值均降低,差异有统计学意义(P<0.05);两组治疗后各个时点VAS评分和ODI值比较,治疗组均优于对照组(P<0.05),见表2、3。两组患者在治疗3个月、6个月后疗效比较,差异均有统计学意义(P<0.05),见表4。两组不良反应结果显示对照组有1例患者出现治疗局部皮肤过敏,治疗组未见明显不良反应。
表2两组患者治疗前后的VAS评分(x±s,分)
注:治疗组与对照组组内与治疗前比较,*P<0.05;治疗组与对照组各个时点同期比较,#P<0.05。
表3两组患者治疗前后的ODI比重(x±s,%)
注:治疗组与对照组组内与治疗前比较,△P<0.05;治疗组与对照组各个时点同期比较,#P<0.05。
表4两组患者治疗后3个月及6个月后的疗效比较(例)
注:同期治疗组与对照组比较,P<0.05。
本发明结果显示,在应用本发明海盐泥中药贴的患者治疗后的各个时点的VAS评分及ODI值均比治疗前低,而且治疗组各个时点的VAS评分和ODI指数均明显优于对照组,治疗后3个月后6个月的总有效率均明显高于对照组,表明该发明海盐泥中药贴有明显的优势。此外,治疗组治疗后6个月的VAS评分和ODI值均较低,由此可见海盐泥中药贴治疗的疗效可以维持较长时间。
综上,本发明自发热海盐泥中药贴可以明显缓解患者颈肩腰背疼痛,并且疗效优于海盐泥加活血化瘀类中药贴。因本发明疗效高、安全、方便、价廉等优点,值得在临床上进一步推广。
下面结合临床实验案例对本发明的应用效果作进一步的描述。
临床实验案例1
患者申某,男,63岁,主诉:腰背痛1周。现病史:患者自诉1周前因受风寒致腰背部疼痛,患者自行卧床休息后症状未见明显缓解,于今日来我院康复中心门诊就诊。既往史:否认高血压、冠心病、糖尿病等病史。专科查体:脊柱生理曲度存在,腰椎活动范围:前屈50°,后伸10°,左右侧屈各10°。L4-S1棘突间及两侧1.5cm处压痛(+),未见明显下肢放射痛。双侧直腿抬高试验均80°(-),双下肢诸肌肌力均V级,双下肢皮肤感觉未见明显异常。双侧Babinski征均(-)。腰部MR提示:各椎体、硬膜囊、椎间盘及神经根未见明显异常。诊断:腰背筋膜炎。治疗:予以实施例1中的海盐泥中药贴日2次外用。1周后复诊患者自诉腰背痛较前缓解,查体:脊柱生理曲度存在,腰椎活动范围:前屈70°,后伸10°,左右侧屈各10°。局部皮肤未见明显红肿、破溃。L4-S1棘突间及两侧1.5cm处压痛(±),未见明显下肢放射痛。双侧直腿抬高试验均80°(-),双下肢诸肌肌力均V级,双下肢皮肤感觉未见明显异常。双侧Babinski征均(-)。嘱患者继续外用海盐泥中药贴日2次。2周后复查,患者自诉腰背痛消失,查体:脊柱生理曲度存在,腰椎活动范围:前屈80°,后伸15°,左右侧屈各15°。局部皮肤未见明显红肿、破溃。L4-S1棘突间及两侧1.5cm处压痛(-),未见明显下肢放射痛。双侧直腿抬高试验均80°(-),双下肢诸肌肌力均V级,双下肢皮肤感觉未见明显异常。双侧Babinski征均(-)。
临床实验案例2
患者赵某,女,46岁,主诉:颈肩背部痛4天。现病史:患者自诉1天前因被空调吹后颈肩背部疼痛,患者自行卧床休息后症状未见明显缓解,于今日来中我院康复中心门诊就诊。既往史:否认高血压、冠心病、糖尿病等病史。专科查体:颈椎,脊柱生理曲度存在,颈椎椎活动范围:前屈25°,后伸25°,左右侧屈各20°。局部皮肤未见明显红肿,左侧胸锁乳头肌处压痛(+),未见明显上肢放射痛。左侧肩背压痛(+),双上肢皮肤感觉未见明显异常。颈部MR提示:各椎体、硬膜囊、椎间盘及神经根未见明显异常。诊断:颈肩部筋膜炎。治疗:予以实施例2中的海盐泥中药贴日2次外用。1周后复诊患者自诉颈肩背部疼痛消失,查体:颈柱生理曲度存在,颈椎活动范围:前屈35°,后伸35°,左右侧屈各40°。颈肩背部压痛(+-),颈肩背及上肢活动自如,局部皮肤感觉未见明显异常。嘱患者继续外用海盐泥中药贴日2次。2周后复查,患者自诉颈肩背痛消失,查体:颈柱生理曲度存在,颈椎活动范围:前屈40°,后伸40°,左右侧屈各45°。治愈。颈肩背部压痛(-),颈肩背及上肢活动自如,局部皮肤感觉未见明显异常。
临床实验案例3
患者李某,女,34岁,主诉:腰背痛4小时。现病史:患者自诉4小时前抬重物致腰背部疼痛,患者自行卧床休息后症状未见明显缓解,于今日来我院康复中心门诊就诊。既往史:否认高血压、冠心病、糖尿病等病史。专科查体:脊柱生理曲度存在,腰椎活动范围:前屈30°,后伸5°,左右侧屈各5°。L3-S1两侧1.5cm处广泛压痛,未见明显下肢放射痛。双侧直腿抬高试验均80°(-),双下肢诸肌肌力均V级,双下肢皮肤感觉未见明显异常。双侧Babinski征均(-)。腰部MR提示:各椎体、硬膜囊、椎间盘及神经根未见明显异常。诊断:急性腰扭伤。治疗:予以实施例3中的海盐泥中药贴日2次外用。1周后复诊患者自诉腰背痛较前缓解,查体:脊柱生理曲度存在,腰椎活动范围:前屈65°,后伸15°,左右侧屈各20°。L3-S1两侧1.5cm处压痛(±),未见明显下肢放射痛。双侧直腿抬高试验均80°(-),双下肢诸肌肌力均V级,双下肢皮肤感觉未见明显异常。双侧Babinski征均(-)。腰部MR提示:各椎体、硬膜囊、椎间盘及神经根未见明显异常。嘱患者继续外用海盐泥中药贴日2次。2周后复查,患者自诉腰背痛消失,查体:脊柱生理曲度存在,腰椎活动范围:前屈85°,后伸20°,左右侧屈各20°。L3-S1两侧1.5cm处压痛(-),未见明显下肢放射痛。双侧直腿抬高试验均80°(-),双下肢诸肌肌力均V级,双下肢皮肤感觉未见明显异常。双侧Babinski征均(-)。腰部MR提示:各椎体、硬膜囊、椎间盘及神经根未见明显异常。
下面结合盐泥的分析对本发明的应用原理作进一步的描述。
中医药学有着悠久的历史,是中华文明的宝库,几千年来,经过历代医家临床实践和经验的积累,已经成为世界范围内广泛应用于临床的治疗方法,并且由于其具有副作用小,临床疗效好,价钱便宜等优点深受广大消费者喜爱。目前,我国正在大力发展健康产业,中医药事业是健康产业的重要组成部分,我国中医药发展规划纲要提出大力推进中医药新药研发和中医药新型治疗方法及其产品的研发,推动中医药产业化的发展。本发明将中医中药和海盐泥结合起来,根据中医辨证论治和理法方药思想,经过多年的实验研究和临床实践总结出四种临床常用中药处方,将中药颗粒剂与海盐泥按一定比例调和,利用海盐泥的保温性能好,渗透性强,粘附作用好等特点,使其作为介质让中药能更有效地透皮吸收,快速到达病所,发挥局部作用。在临床治疗上是具有可行性和有效性的,值得大力推广应用。
盐泥保温效果好,并能持续一定的时间,利用物理热效应将热度渗透至体内,驱散体内寒气,使局部毛细血管扩张,局部组织血液循环加快,淋巴回流增加,可缓解和消除平滑肌痉挛。使局部的皮肤组织代谢能力加强,可促进炎症、瘢痕、浮肿、粘连、渗出物、血肿等病理产物的消散吸收,又有镇痛作用。热敷又使汗腺分泌增加,有利于代谢产物的排泄,末梢血管扩张会使血压下降,同时还引起大脑皮层抑制的扩散,降低神经系统的兴奋性,有镇静作用。盐泥渗透性能强,通过盐的高渗作用和紧密粘附使皮肤外盐泥与人体组织间液之间形成浓度梯度差,将水肿部位的组织间液中的水分吸附到盐泥上缓解水肿的情况。盐泥中含有丰富的矿物质和微量元素,附着于体表,有的通过对皮肤的剌激发挥作用,有的通过皮肤进入体内。附着于体表的元素可在皮肤表面形成电离层,这些离子可剌激皮肤神经末梢,通过对神经一体液系统的调节,对人体的生理活动、物质代谢产生影响。通过皮肤进入体内的元素,它们作为酶、激素、维生素核酸的成分,在细胞调节、神经传导、免疫应答等方面起着关键性的作用,从而起到改善机体组织营养供应、增强血液和淋巴循环、促进吸收和再生能力、提高免疫力和调节内分泌等功能。
盐泥吸附性能好,由于泥中含各种微小砂土颗粒及大量胶体物质,当其与皮肤密切接触时,对机体可产生一定的压力和摩擦剌激,产生类似按摩的机械作用,缓解局部的肌肉紧张状态。除对组织产生压迫、松驰、疏通气血作用外,又可将盐泥利用按摩、推拿的方法在机体表面推搓,在摩擦力学作用下,使血流、淋巴液循环加快。泥土颗粒细腻,和皮肤生成的机械摩擦,能去除皮肤表面的病理脱皮、生理陈皮,有利于新皮的生成,对牛皮癣、鱼鳞病等皮肤病较适合。吸附作用泥土的粘滞性较强,并含大量炭化物,多面孔的晶体细颗粒,均有一定的吸附作用,可将皮肤表面的汗垢、细菌、代谢产物、尘埃物等吸附,除治疗一些皮肤病外,亦有护肤美容的作用。通过盐泥与皮肤的充分接触和热效应使中药能更好的渗入人体,直接作用于病灶所在部位,增加局部的药物浓度和药物作用时间,使药物充分发挥作用。
对于疾病的治疗作用
适应症:慢性多发性关节炎(除结核病)、风湿性关节炎(急性期过后六个月以上才能进行泥疗)、慢性脊椎关节炎、脊髓及脊髓膜外伤后遗症、骨折迟迟不愈合、骨髓炎(除结核病)、慢性肌炎、腱鞘炎、神经炎、多发性脊髓神经根炎、神经痛、周围神经系病、周围神经外伤后遗症、营养性溃疡、静脉曲张、周围静脉炎、血栓闭塞性静脉炎(急性则用冷泥、慢性用热泥)、外伤瘢痕、抽搐、粘连或萎缩、腹腔内脏腑慢性炎症、腹腔器官粘连、慢性前列腺炎、慢性副睾丸炎(除结核病〉、妇女盆腔炎、卵巢功能减弱、慢性副鼻窦炎、慢性中耳炎等病症均可用盐泥疗法施治。
对于亚健康状态的保健作用
解除疲劳:脑力劳动者长期伏案工作,容易造成项背部肌肉的慢性劳损;体力劳动过重者容易造成腰、腿、肩、肘等部的肌肉疲劳。而无论哪个部位的疲劳,在疲劳、酸痛的部位使用,可以加速局部的血液循环及淋巴回流,增强局部组织的营养供应,促进有毒物质的排出,从而解除疲劳状态。
调节精神紧张:现代社会生活节奏加快,各个行业,各个领域的竞争激烈,再加上营养配置不合理,环境污染严重,体育锻炼少,活动空间狭窄,人们常常觉得身体疲惫、精神紧张、大脑疲劳。医学上称这种感觉为精神紧张综合症,能量泥灸可以消除精神紧张,解除大脑疲劳。
消除各种疼痛:中医认为"不通则痛,通则不痛",疼痛主要是由于经络、气血痕滞不通所致。能量泥灸具有疏通经络、行气活血、桂除疲滞的作用。中药盐泥对于急性腰扭伤、落枕、头痛等疾病,可起到立竿见影止痛之效。具有缓解疼痛的作用。
目前已经开展了100余例患者的中药盐泥治疗,涉及的疾病包括:不同类型颈椎病,肩周炎,风湿类风湿性关节炎,痛风性关节炎,网球肘,臆鞠炎,滑膜炎,腰椎间盘突出,老年性骨关节退化,腹泻,痛经,失眠,更年期综合症,消化不良等疗效显著,下附具体典型病例予以说明。
典型病例
1肩周炎
患者,刘xx,男,53岁,工人,初诊日期:2017年5月17日。病史:左肩部反复疼痛伴活动受限10余年。患者因从事重体力劳动多年,造成左肩关节反复疼痛,初始未注意未及时就诊,后渐觉左肩关节外展和上抬活动受限并伴有疼痛,劳累后或湿雨天气时加重。今日疼痛发作频繁,左上股沉重如裹,恶风,夜间需在左肩包裹毛巾方能入睡,影响日常生活,舌淡红,苔自腻,脉浮紧。
诊断:西医:肩关节周围炎中医:风寒湿痹症
治疗:取祛风止痛中药盐泥用微波炉加热至42~43摄氏度,患者取坐位或侧卧位,暴露左肩部皮肤,保证皮肤干燥洁净,将加热好的盐泥外敷于左肩部,面积覆盖左侧肩关节皮肤,前至第三肋间,侧至三角肌下缘,后至肩月甲骨冈上窝。持续30分钟后取下中药盐泥,温水洁净局部皮肤。隔日一次,一周4次为一疗程,并嘱托病人回去做"侧向爬墙锻炼",增加肩关节活动性。
2017年5月26日复诊:治疗后肩关节疼痛程度较之前明显缓解,发作频率较之前减少,遇刮风寒湿天气肩关节疼痛酸胀较之前好转,肩关节活动范围较之前增大。舌淡红,苔薄白,脉细。复予中药盐泥外敷治疗一疗程后,患者肩关节疼痛及活动受限基本消失,且随访三月,仅发作1次。
2颈椎病
患者,郝XX,女,33岁,行政科员,初诊日期:2017年6月19日。病史:颈部板滞疼痛伴头晕2年余。患者因经常伏案工作,颈部常反复出现板滞疼痛,伴有项背肌肉紧张疼痛,严重时可有头晕恶心,劳累后可加重。舌暗红,苔薄白,舌下络脉增粗,脉细涩。
诊断:西医:椎动脉型颈椎病中医:血瘀痹症
治疗:取活血通络中药盐泥用微波炉加热至42-43摄氏度,患者取坐位或俯卧位,暴露颈部皮肤,保证皮肤干燥洁净,将加热好的盐泥外敷于颈部部,面积覆盖后发际线至两侧肩胛骨冈上窝,持续30分钟后取下中药盐泥,温水洁净局部皮肤。隔日一次,一周4次为一疗程,并嘱托工作之余做颈部保健操。
2017年6月28日复诊:治疗当日患者即觉颈部疼痛板滞明显缓解,坚持1疗程后症状完全缓解,未出现任何头晕恶心呕吐等症状。
3腰推间盘突出
患者,郑XX,女,46岁,农民,初诊日期:2018年4月12日。
病史:腰胯部反复疼痛十余年。自第五腰椎下,连及右侧腰肌、髓关节、臀大肌、坐骨神经分布沿线持续酸痹,间歇剧痛,未能根治。近三日来症状加重,筋脉孪急,转侧,俯仰活动受限,动则掣痛难忍。舌质淡红,苔白腻,舌下见淤点,脉沉紧。
诊断:西医:腰椎间盘突出中医:寒湿痹症
治疗:取温经散寒中药盐泥用微波炉加热至42--43摄氏度,患者取俯卧位,暴露腰臀部皮肤,保证皮肤干燥洁净,将加热好的中药盐泥外敷于腰臀部,面积覆盖第五腰椎以下至双侧臀大肌。持续30分钟后取下盐泥,温水洁净局部皮肤。隔日一次,一周4次为一疗程。
4月19日复诊:治疗后腰臀疼痛明显减轻,能下田参加劳动。但骤为劳累。又见腰臀酸胀疼痛加重。其舌苔转薄白,脉转细弦,乃寒湿渐化之征。复予中药盐泥外敷治疗一疗程。至4月28日复诊腰臀疼痛基本消除,下地活动自如。
4痛经
患者,陆Xx,女,21岁,学生,初诊日期:2018年6月14日。
病史:反复经期腹部冷痛8年加重一周。患者13岁月经初潮时即有痛经,持续至今,每月必致,下腹部冷痛,外敷热水袋能有所缓解,疼痛剧烈时需服用止痛方能缓解,面部痤疮频发,肤色黯黄,胃纳不佳,大便黏腻不爽,3-4日一行,月经有血块。近一周经期腹痛复作,舌淡苔薄自腻,脉细涩。
诊断:西医:痛经中医:痛经
治疗:待患者月经周期过后进行治疗,取排毒养颜中药盐泥用微波炉加热至42-43摄氏度,患者取仰卧位,暴露腹部皮肤,保证皮肤干燥洁净,将加热好的中药盐泥外敷于腹部,面积覆盖脐水平以下水平至毛发上缘。持续30分钟后取下盐泥,温水洁净局部皮肤。隔日一次,一周4次为一疗程。
6月21日复诊:治疗后患者面部瘟疮较之前明显减少,大便爽利,至下月经期时腹痛较之前有明显改善,复予中药盐泥外敷治疗三个疗程,患者痛经情况逐渐缓解。
盐泥纯天然、环保、渗透快、效果好,无任何副作用,安全对人体无伤害。经过临床试验本发明发现中药盐泥的临床效果很好,且患者在治疗过程无痛苦,操作简便快捷,价格低廉,便于基层医院开展治疗项目和连锁药房销售供患者在家里自行治疗。中药盐泥不仅对己有疾病具有治疗作用,更可以有效改善当代人常见的亚健康状态,体现中医的“治未病”思想,将疾病扼杀在萌芽状态,明显地改善患者的生活质量。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,其特征在于,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴为药膏层与自发热层上下两层;药膏贴中含有海盐泥和中药成分;海盐泥和中药成分的质量比为1:1。
2.如权利要求1所述的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,其特征在于,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的中药成分按照重量份数由当归2-6份、杜仲叶2-6份、乌梢蛇2-6份、木瓜1-3份、三七1-3份、葛根3-9份、姜黄2-6份、花椒2-6份、山茱萸1-3份、黄芪2-6份、肉桂1-3份、枸杞子1-3份、干姜1-3份、桑椹2-6份和甘草1-3份组成。
3.如权利要求2所述的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,其特征在于,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴中药成分按照重量份数由当归2份、杜仲叶2份、乌梢蛇2份、木瓜1份、三七1份、葛根3份、姜黄2份、花椒2份、山茱萸1份、黄芪2份、肉桂1份、枸杞子1份、干姜1份、桑椹2份和甘草1份组成。
4.如权利要求2所述的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,其特征在于,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴中药成分按照重量份数由当归4份、杜仲叶4份、乌梢蛇4份、木瓜2份、三七2份、葛根6份、姜黄4份、花椒4份、山茱萸2份、黄芪4份、肉桂2份、枸杞子2份、干姜2份、桑椹4份和甘草2份组成。
5.如权利要求2所述的用于缓解颈肩腰背疼痛的自发热海盐泥中药贴,其特征在于,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴中药成分按照重量份数由当归6份、杜仲叶6份、乌梢蛇6份、木瓜3份、三七3份、葛根9份、姜黄6份、花椒6份、山茱萸3份、黄芪6份、肉桂3份、枸杞子3份、干姜3份、桑椹6份和甘草3份组成。
6.一种如权利要求1所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的制备方法,其特征在于,所述用于缓解颈肩腰背疼痛的自发热海盐泥中药贴的制备方法包括:
步骤一,对原材料去外衣和消毒;
步骤二,分别称取海盐泥及中药饮片颗粒剂,干燥处理,干燥温度控制在35-40℃;
步骤三,分别将海盐泥和中药饮片颗粒剂放入打粉机中打成海盐泥粉及中药颗粒粉剂,样品筛为200目;
步骤四,将医用压敏膏药胶加热到130°融化后先后放入中药粉剂及海盐泥粉剂,制成药膏放入防渗圈中;
步骤五,将步骤四中的药膏贴与自发热包粘贴在一起;
步骤六,将做好的小包装产品打好相应生产日期,套好包装膜进行热收缩;
步骤七,成品放入库房的产品合格区。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910747862.3A CN110368478A (zh) | 2019-08-14 | 2019-08-14 | 一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910747862.3A CN110368478A (zh) | 2019-08-14 | 2019-08-14 | 一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110368478A true CN110368478A (zh) | 2019-10-25 |
Family
ID=68259147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910747862.3A Pending CN110368478A (zh) | 2019-08-14 | 2019-08-14 | 一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110368478A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642548A (zh) * | 2009-08-27 | 2010-02-10 | 吴清玲 | 治疗腰腿疼痛的中药膏贴及其制备方法 |
CN105214055A (zh) * | 2015-11-03 | 2016-01-06 | 深圳市灵兰思远有限公司 | 一种治疗颈肩腰腿痛、关节炎的中药组合物及制备方法 |
CN106963937A (zh) * | 2017-05-16 | 2017-07-21 | 林明芳 | 一种肩颈痛外敷配方 |
CN109260416A (zh) * | 2018-10-10 | 2019-01-25 | 辽宁中医药大学 | 一种用于缓解气滞血瘀型腰背疼痛的自发热海泥药物贴 |
-
2019
- 2019-08-14 CN CN201910747862.3A patent/CN110368478A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642548A (zh) * | 2009-08-27 | 2010-02-10 | 吴清玲 | 治疗腰腿疼痛的中药膏贴及其制备方法 |
CN105214055A (zh) * | 2015-11-03 | 2016-01-06 | 深圳市灵兰思远有限公司 | 一种治疗颈肩腰腿痛、关节炎的中药组合物及制备方法 |
CN106963937A (zh) * | 2017-05-16 | 2017-07-21 | 林明芳 | 一种肩颈痛外敷配方 |
CN109260416A (zh) * | 2018-10-10 | 2019-01-25 | 辽宁中医药大学 | 一种用于缓解气滞血瘀型腰背疼痛的自发热海泥药物贴 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100560124C (zh) | 一种治疗骨质增生症及疼痛的膏药及其制备方法 | |
CN113456779A (zh) | 一种按摩涂抹中药药酒及其制备方法和应用 | |
CN109200144A (zh) | 一种中药组合物及其应用和膏药 | |
CN104815295A (zh) | 一种治疗颈椎病的中药制剂 | |
CN106880782A (zh) | 祛病强身药枕 | |
CN104491675B (zh) | 活血化瘀汤 | |
CN103385941B (zh) | 中草药止痛药灸 | |
CN110368478A (zh) | 一种用于缓解颈肩腰背疼痛的自发热海盐泥中药贴 | |
CN109260416A (zh) | 一种用于缓解气滞血瘀型腰背疼痛的自发热海泥药物贴 | |
CN102309741B (zh) | 一种治疗经久不敛型褥疮的中药洗剂制备方法 | |
CN104958727A (zh) | 一种治疗儿童哮喘缓解期的中药组合物及其应用 | |
CN104940304A (zh) | 一种用于离子导入疗法的治疗儿童哮喘缓解期的敷贴 | |
Browne | Natural Therapies for Overcoming Opioid Dependency: Control Pain and Recover from Addiction with Chinese Medicine, Acupuncture, Herbs, Nutritional Supplements & Meditation and Lifestyle Practices | |
CN104435798A (zh) | 改善神经衰弱的中药制剂及其制备方法 | |
CN103494948A (zh) | 一种治疗高血压高血糖高血脂的中草药 | |
CN103157006A (zh) | 治疗骨关节炎的内服中药方剂 | |
CN102343081A (zh) | 一种治疗疼痛病纯中药制剂的灸具及治疗疼痛病的纯中药制剂 | |
CN108452260A (zh) | 一种外用通络止痛的植物精油 | |
CN102133380A (zh) | 一种治疗颈椎病的药物 | |
CN108159276A (zh) | 一种熏蒸液及其制备方法和使用方法 | |
CN1055841C (zh) | 治疗婴幼儿肺炎的外贴药膏及应用外贴药膏的外用药贴的制备方法 | |
CN106421636A (zh) | 一种治疗骨关节病及软组织增生的中药药物和磁疗贴 | |
CN105168838A (zh) | 一种治疗咽喉炎的中药组合物及其制剂 | |
CN104306893B (zh) | 一种用于脑外伤后半侧肢体失灵的中药制剂及其制备方法 | |
Beinfield et al. | Dao and the doctor: the thought and practice of Chinese medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191025 |
|
RJ01 | Rejection of invention patent application after publication |